Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	8,097	7,702	7,516	7,475	5,772
Revenue Growth (YoY)	5.13%	2.48%	0.55%	29.49%	-16.26%
Cost of Revenue	4,305	4,007	4,136	4,031	3,375
Gross Profit	3,792	3,695	3,380	3,444	2,397
Selling, General & Admin	1,498	1,394	1,160	1,045	811.69
Other Operating Expenses	1,027	795.34	1,047	1,212	502.63
Operating Expenses	2,819	2,453	2,394	2,431	1,502
Operating Income	972.66	1,242	986.49	1,013	894.47
Interest Expense	-77.5	-60.51	-98.64	-36.93	-43.01
Interest & Investment Income	151.49	117.9	75.05	88.18	95.79
Currency Exchange Gain (Loss)	160.06	111.35	77.69	200.57	78.86
Other Non Operating Income (Expenses)	44.47	44.93	16.48	14.99	15.47
EBT Excluding Unusual Items	1,251	1,456	1,057	1,280	1,042
Gain (Loss) on Sale of Investments	1.93	1.72	-	-	-
Gain (Loss) on Sale of Assets	-	2.86	3.65	0.68	-0.31
Asset Writedown	-	-	-	-3.06	-
Other Unusual Items	-	-291.96	-	-735.95	-
Pretax Income	1,256	1,169	1,061	541.65	1,041
Income Tax Expense	353.84	352.94	293.37	310.39	301.55
Earnings From Continuing Operations	902.55	815.78	767.35	231.27	739.72
Net Income to Company	902.55	815.78	767.35	231.27	739.72
Minority Interest in Earnings	-59.56	-61.24	-58.76	-80.86	-54.81
Net Income	842.99	754.54	708.59	150.4	684.91
Net Income to Common	842.99	754.54	708.59	150.4	684.91
Net Income Growth	11.72%	6.49%	371.13%	-78.04%	-29.58%
Shares Outstanding (Basic)	105	104	104	103	103
Shares Outstanding (Diluted)	106	106	105	105	105
Shares Change (YoY)	-0.04%	0.56%	0.26%	-0.26%	2.26%
EPS (Basic)	8.02	7.23	6.83	1.46	6.64
EPS (Diluted)	7.95	7.11	6.72	1.43	6.49
EPS Growth	11.81%	5.80%	369.93%	-77.97%	-31.18%
Free Cash Flow	298.48	744.87	-594.86	614.78	548.45
Free Cash Flow Per Share	2.81	7.02	-5.64	5.84	5.20
Dividend Per Share	0.500	0.500	0.500	0.500	0.500
Gross Margin	46.83%	47.98%	44.98%	46.07%	41.52%
Operating Margin	12.01%	16.13%	13.13%	13.55%	15.50%
Profit Margin	10.41%	9.80%	9.43%	2.01%	11.87%
Free Cash Flow Margin	3.69%	9.67%	-7.92%	8.22%	9.50%
EBITDA	1,223	1,479	1,160	1,166	1,042
EBITDA Margin	15.10%	19.20%	15.43%	15.60%	18.06%
D&A For EBITDA	249.85	236.6	173.54	152.62	147.88
EBIT	972.66	1,242	986.49	1,013	894.47
EBIT Margin	12.01%	16.13%	13.13%	13.55%	15.50%
Effective Tax Rate	28.16%	30.20%	27.66%	57.30%	28.96%
Revenue as Reported	8,462	7,990	7,694	7,789	5,974
Advertising Expenses	72.5	84.27	61.7	48.05	18.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.